AutoLumo CLIA Cardiac Markers, 100 Tests

The AutoLumo CLIA Cardiac Marker Microparticles Series offers a high-performance range of chemiluminescent immunoassay (CLIA) reagents designed for rapid, quantitative determination of cardiac biomarkers in human serum or plasma.

Utilizing magnetic microparticle CLIA technology, these reagents provide exceptional sensitivity, precision, and reproducibility, enabling early diagnosis, risk assessment, and monitoring of acute myocardial infarction (AMI), heart failure, and cardiac injury.

All reagents are designed for fully automated operation on AutoLumo CLIA Analyzers, delivering reliable and standardized performance in both emergency and routine clinical diagnostics.

Key Features

• High Analytical Sensitivity: Detects minute concentrations of cardiac proteins and peptides.
• Magnetic Microparticle CLIA Technology: Ensures accurate, consistent chemiluminescent signal generation.
• Rapid Turnaround: Ideal for emergency and high-throughput cardiac testing laboratories.
• Automation Ready: Fully compatible with AutoLumo CLIA Analyzer Series.
• Clinical Reliability: CE-marked assays available for regulated diagnostic use.
• Wide Clinical Coverage: Includes markers for myocardial infarction, cardiac failure, and heart stress.
• Stable and Long Shelf Life: Maintains assay integrity for consistent performance.

Product Range

Clinical Applications

• Acute Myocardial Infarction (AMI):
  • Troponin I (cTnI), Troponin T (HS-cTnT), CK-MB, Myoglobin — for early and definitive detection of myocardial injury.
• Heart Failure and Cardiac Dysfunction:
  • BNP and NT-proBNP — for diagnosis, prognosis, and monitoring of congestive heart failure.
• Cardiac Stress and Risk Assessment:
  • High-sensitivity Troponins (HS-cTnI, HS-cTnT) — for predictive and long-term cardiovascular evaluation.
• Monitoring Cardiac Therapy:
  • Tracking response to pharmacologic and surgical interventions in cardiac patients.

Performance Characteristics

• Detection Method: Chemiluminescent Immunoassay (CLIA)
• Technology: Magnetic Microparticle-Based Sandwich Immunoassay
• Sample Type: Human Serum or Plasma
• Precision: Coefficient of Variation (CV) ≤ 10%
• Storage Conditions: 2–8°C, protected from light
• Shelf Life: 12 months from manufacturing date

Unique Advantages

• Comprehensive panel for cardiac risk detection and monitoring.
• CE-marked assays for clinical diagnostic reliability.
• Fully automated, high-throughput compatibility with AutoLumo analyzers.
• High sensitivity for early diagnosis of cardiac events.
• Excellent correlation with international reference assays.
• Reliable results for emergency laboratory testing environments.

The AutoLumo CLIA Cardiac Marker Microparticles Series provides a complete set of high-sensitivity chemiluminescent reagents for the detection of critical cardiac biomarkers.

With automated compatibility, precision-engineered microparticles, and CE-marked accuracy, this series enables early detection and continuous monitoring of cardiovascular diseases.

Ideal for hospital emergency labs, cardiology centers, and clinical diagnostics laboratories, AutoLumo’s cardiac reagent panel supports accurate, rapid, and reproducible cardiac testing for improved patient outcomes.